SURVYR

Markets

Deals, catalysts and today's big movers

Takeovers, FDA dates and the biggest moves, from filings and headlines.

Pending deals 10

Deal odds

Announced takeovers and the gain to the offer price.

BRZE Braze, Inc.
Salesforce · $47.50 cash · announced 10/20 · close: Salesforce fiscal 2028 (Feb 2027 - Jan 2028) · Odds › Scorecard ›
+3.8%
$45.78AH
Salesforce Signs Definitive Agreement to Acquire Braze ($47.50 per share in cash)
MG Mistras Group Inc
H.I.G. Capital · $20.35 cash · announced 09/18 · Go-shop period runs through Oct 27, 2026 · Odds › Scorecard ›
+1.4%
$20.07AH
MISTRAS Group, Inc. Enters into Definitive Agreement to Be Acquired by H.I.G. Capital for $20.35 Per Share in Cash
HZO MarineMax, Inc. (FL)
Safe Harbor Marinas (Blackstone Infrastructure) · $53.00 cash · announced 08/10 · close: By end of 2026 · Odds › Scorecard ›
+1.0%
$52.48AH
MarineMax Enters into Definitive Agreement to be Acquired by Safe Harbor in a $1.5 Billion All-Cash Transaction ($53.00 per share)
CBZ CBIZ, Inc.
Grant Thornton Advisors · $55.00 cash · announced 07/29 · close: Q4 2026 · Odds › Scorecard ›
+0.3%
$54.85AH
Grant Thornton Advisors to Acquire CBIZ for $5 Billion ($55.00 per share in cash)

Other deal headlines (target or price not parsed)

Takeover watch

Score

Early signs a company may be sold. Most never become deals.

Sale and buyout reports, last 30 days

New SC 13D stakes (SEC), last 3 weeks

SNES SenesTech, Inc.Takeover 35
Filed by LeBeau Justin Michael · 10/26 · filing · Scorecard ›
-1.3%
$0.84
CPSH CPS Technologies Corp.Takeover 35
Filed by Global Value Investment Corp. · 10/26 · filing · Scorecard ›
-7.0%
$3.38
CTY City Therapeutics, Inc.Takeover 35
Filed by ARCH Venture Fund XII, L.P. · 10/26 · filing · Scorecard ›
+0.3%
$20.86
AZUL Azul S.A.Takeover 55
Filed by American Airlines Group Inc. · 10/26 · filing · Scorecard ›
+2.3%
$3.54
BBCI Bradbury Capital Inc.Takeover 35
Filed by Ong Mei Yoong · 10/23 · filing · Scorecard ›
-1.1%
$1.85
ABEO Abeona Therapeutics Inc.Takeover 35
Filed by James Russell Revocable Trust · 10/23 · filing · Scorecard ›
+0.9%
$4.49
BBCI Bradbury Capital Inc.Takeover 35
Filed by Yong Teck Hong · 10/22 · filing · Scorecard ›
-1.1%
$1.85
AACG ATA Creativity GlobalTakeover 35
Filed by Everrise Holdings Llc · 10/22 · filing · Scorecard ›
-5.2%
$0.69
MAT Mattel, Inc.Takeover 70
Filed by EdgePoint Investment Group Inc. · 10/22 · filing · Scorecard ›
-0.1%
$15.42
POLA Polar Power, Inc.Takeover 35
Filed by Mayer Christopher Jay · 10/21 · filing · Scorecard ›
+5.8%
$0.68

Unusual volume (last session vs 3-month average)

Biotech catalysts 6

FDA decision dates and phase 3 results.

Upcoming FDA decision dates

10/04/2026 Eisai Co Ltd
WELIREG plus LENVIMA (sNDA): FDA decision on WELIREG plus LENVIMA in patients with advanced renal cell carcinoma (RCC)
RTTNews FDA calendar · decision pending
10/10/2026 MRK Merck & Company, Inc.+0.0%
$141.82AH
Ifinatamab deruxtecan (I-DXd) (BLA): FDA decision on ifinatamab deruxtecan for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC)
RTTNews FDA calendar · decision pending
10/10/2026 Daiichi Sankyo Company Limited
Ifinatamab deruxtecan (I-DXd) (BLA): FDA decision on ifinatamab deruxtecan for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC)
RTTNews FDA calendar · decision pending

Recent FDA decisions

Q4 2026 PFE Pfizer, Inc.-0.0%
FDA expanded approval of TALZENNA in combination with XTANDI to the treatment of men with metastatic androgen pathway modulation-naïve or -sensitive prostate ca
FDA approved WELIREG plus LENVIMA in patients with advanced renal cell carcinoma on Sep.25, 2026
10/15/2026 Roche Holding AG
FDA approved Enspryng (satralizumab) for the treatment of adults with thyroid eye disease on 16th Oct. 2026.
10/17/2026 VTRS Viatris Inc.+0.4%
FDA approved RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults on 16th Oct. 2026
10/17/2026 IRD Opus Genetics, Inc.+0.0%
FDA approved RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults on 16th Oct. 2026

Phase 3 readouts, last 3 weeks

Live movers

After hours · closed

Today's biggest moves and deal targets.

Pre/after-hours volume isn't available from our data source. These moves are ranked on price only.

Prices as of 19:59 ET

After-hours setups

Biggest moves after the close.

Gapping up

Gapping down

Earnings today: before the open

KO Coca-Cola Company (The)
EPS est. $0.87
+0.1%
$91.23AH
NVS Novartis AG
EPS est. $2.25
-0.2%
$156.49AH
BA Boeing Company (The)Takeover 20
EPS est. ($0.21)
+0.2%
$168.50AH
SPGI S&P Global Inc.
EPS est. $4.43
-0.2%
$448.00AH
GLW Corning Incorporated
EPS est. $0.89
+0.1%
$126.43AH
HCA HCA Healthcare, Inc.
EPS est. $6.74
-0.0%
$449.86AH
FCX Freeport-McMoRan, Inc.
EPS est. $0.80
+0.1%
$66.03AH
JCI Johnson Controls International
EPS est. $1.58
+0.0%
$155.88AH

Earnings today: after the close

V Visa Inc.
EPS est. $3.43
-1.1%
$397.25AH
STX Seagate Technology Holdings PLC
EPS est. $7.17
-5.5%
$631.00AH
WM Waste Management, Inc.
EPS est. $2.18
-1.5%
$232.22AH
HOOD Robinhood Markets, Inc.
EPS est. $0.56
-7.6%
$87.34AH
NXPI NXP Semiconductors N.V.
EPS est. $3.78
-7.3%
$234.98AH
OKE ONEOK, Inc.
EPS est. $1.46
-0.2%
$95.85AH
BKR Baker Hughes Company
EPS est. $0.63
-0.5%
$58.70AH
TER Teradyne, Inc.
EPS est. $2.04
-5.1%
$307.05AH
How this works

Pending deals: announced acquisitions of U.S.-listed companies. Spread is the gain to the offer price if the deal closes as agreed. Deals can still break.

Takeover watch: sale and buyout reports, new 5%+ activist or strategic stakes (SC 13D), and unusual trading volume. These often come before a deal, but most never turn into one.

Biotech: FDA decision (PDUFA) dates and phase 3 readouts from company and news headlines plus RTTNews's public FDA calendar. There is no complete free source, so this list is partial.

Movers: moves of 3% or more in U.S. stocks over $300M market cap. Premarket gaps show from 4:00 AM ET and after-hours moves from 4:00 PM ET. Extended-hours trading is thin and prices can reverse at the open. Live movers tiles use TradingView charts; U.S. stock quotes in TradingView widgets are delayed (Cboe One) and the chart shows the regular session.

Scorecard: every alert on this page is logged with its time and price and graded at 1 day, 1 week and 1 month on the Scorecard, losers included.

Sources: Yahoo Finance quotes and headlines (delayed), the SURVYR. news feed, SEC EDGAR full-text search (SC 13D), Nasdaq earnings calendar, RTTNews FDA calendar, TradingView widgets. Offer prices come from company announcements and headlines; when a price can't be read it's left blank. Refreshed every 15 minutes on weekdays.

Research only. Important disclosures.

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Coteau 0.9 · Oct 21, 2026